Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-226971
Filing Date
2020-08-21
Accepted
2020-08-21 16:05:25
Documents
4
Effectiveness Date
2020-08-21

Document Format Files

Seq Description Document Type Size
1 S-8 d98050ds8.htm S-8 41683
2 EX-5.1 d98050dex51.htm EX-5.1 5756
3 EX-23.1 d98050dex231.htm EX-23.1 1485
4 GRAPHIC g98050dsp11logo.jpg GRAPHIC 3084
  Complete submission text file 0001193125-20-226971.txt   54525
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-248232 | Film No.: 201123466
SIC: 2834 Pharmaceutical Preparations